Inventor · disambiguated record
Ingegerd Hellstrom
Also filed as: HELLSTROEM INGEGERD · HELLSTROM INGEGERD · HELLSTROM INGEGERD E
33 granted patents·12 pending applications·1,887 citations·filing 1984–2020
98Inventor score
Files withONCOGEN19BRISTOL MYERS SQUIBB CO7PACIFIC NORTHWEST RES INST6HELLSTROM INGEGERD2HELLSTROM KARL ERIK2
Top patents by PatentIndex Score
45 records- 0196US5171665AMonoclonal antibody to novel antigen associated with human tumorsONCOGEN·Filed 1989·Granted Dec 15, 1992·211 cites·24 claims
- 0295US5134075AMonoclonal antibody to novel antigen associated with human tumorsONCOGEN·Filed 1989·Granted Jul 28, 1992·143 cites·21 claims
- 0395US5091178ATumor therapy with biologically active anti-tumor antibodiesONCOGEN·Filed 1990·Granted Feb 25, 1992·158 cites·3 claims
- 0495US4918164ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1987·Granted Apr 17, 1990·132 cites·14 claims
- 0594US6770445B1Methods and compositions for diagnosing carcinomasPACIFIC NORTHWEST RES INST·Filed 2000·Granted Aug 3, 2004·78 cites·3 claims
- 0693US5262177ARecombinant viruses encoding the human melanoma-associated antigenONCOGEN·Filed 1987·Granted Nov 16, 1993·123 cites·34 claims
- 0792US5811098AAntibodies to HER4, human receptor tyrosine kinaseBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 22, 1998·123 cites·17 claims
- 0891US7270960B2Diagnosis of ovarian carcinomasPACIFIC NORTHWEST RES INST·Filed 2002·Granted Sep 18, 2007·33 cites·42 claims
- 0990US4997913ApH-sensitive immunoconjugates and methods for their use in tumor therapyONCOGEN·Filed 1987·Granted Mar 5, 1991·68 cites·25 claims
- 1089US5980896AAntibodies reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Nov 9, 1999·104 cites·35 claims
- 1188US4935495AMonoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomasONCOGEN·Filed 1984·Granted Jun 19, 1990·45 cites·16 claims
- 1287US4906562AMonocolonal antibodies and antigen for human non-small cell lung carcinomasONCOGEN·Filed 1985·Granted Mar 6, 1990·61 cites·28 claims
- 1386US5091177AMonoclonal antibodies for treatment of human non-small cell lung carcinomasONCOGEN·Filed 1990·Granted Feb 25, 1992·59 cites·33 claims
- 1485US5491088AMonoclonal antibody BR 96 and chimeric monoclonal antibodies having the variable region of MAB BR96, which bind to a variant of ley antigen on human carcimona cellsONCOGEN·Filed 1993·Granted Feb 13, 1996·63 cites·12 claims
- 1585US5242824AMonoclonal antibody to human carcinomasONCOGEN·Filed 1989·Granted Sep 7, 1993·69 cites·8 claims
- 1684US7547681B2Surface receptor antigen vaccinesUNIV WASHINGTON·Filed 2004·Granted Jun 16, 2009·12 cites·11 claims
- 1784US6734172B2Surface receptor antigen vaccinesPACIFIC NORTHWEST RES INST·Filed 1999·Granted May 11, 2004·60 cites·7 claims
- 1884US4737579AMonoclonal antibodies for human non-small cell lung carinomasONCOGEN·Filed 1986·Granted Apr 12, 1988·35 cites·24 claims
- 1983US5840854AMonoclonal antibody BR110 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Nov 24, 1998·54 cites·22 claims
- 2077US5165922ASynergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapyBRISTOL MYERS SQUIBB CO·Filed 1990·Granted Nov 24, 1992·58 cites·2 claims
- 2176US5597707ATumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their useBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Jan 28, 1997·41 cites·13 claims
- 2275US5185432AMonoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomasONCOGEN·Filed 1986·Granted Feb 9, 1993·19 cites·18 claims
- 2375US5141742AVaccines against melanomaONCOGEN·Filed 1991·Granted Aug 25, 1992·48 cites·16 claims
- 2474US9090712B2Diagnosis of carcinomasHELLSTROM INGEGERD·Filed 2009·Granted Jul 28, 2015·1 cites·2 claims
- 2571US5614610ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1988·Granted Mar 25, 1997·19 cites·5 claims
- 2664US6020145AMethods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96BRISTOL MYERS SQUIBB CO·Filed 1994·Granted Feb 1, 2000·17 cites·4 claims
- 2763US9822169B2Compositions and methods of use for determination of HE4aHELLSTROM INGEGERD·Filed 2011·Granted Nov 21, 2017·1 cites·6 claims
- 2862US6183734B1Inhibition of tumor cell growth by administration of B7-transfected cellsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Feb 6, 2001·22 cites·9 claims
- 2962US2009104684A1Diagnosis of carcinomasPACIFIC NORTHWEST RES INST·Filed 2007·Application pending·0 cites
- 3060US2018217158A1Methods for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cellsUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2018·Application pending·0 cites
- 3156US7745159B2Methods and compositions for diagnosing carcinomasSCHOLLER NATHALIE B·Filed 2004·Granted Jun 29, 2010·3 cites·27 claims
- 3255US2020325215A1COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4aPACIFIC NORTHWEST DIABETES RES INSTITUTE·Filed 2020·Application pending·0 cites
- 3352US5055559AAnti-melanoma antibody MG-21 for diagnosis and therapy of human tumorsONCOGEN·Filed 1986·Granted Oct 8, 1991·13 cites·4 claims
- 3452US2016033512A1Diagnosis of carcinomasPACIFIC NORTHWEST RES INST·Filed 2015·Application pending·0 cites
- 3552US2013224772A1Method for detecting anti-he4 antibodies and methods of diagnosis and/or prognosis of conditions associated with he4-expressing cellsHELLSTROM KARL ERIK·Filed 2011·Application pending·0 cites
- 3650US2018057575A1COMPOSITIONS AND METHODS OF USE FOR DETERMINATION OF HE4aPACIFIC NORTHWEST DIABETES RES INSTITUTE·Filed 2017·Application pending·0 cites
- 3750US2009042224A1Methods for diagnosis and/or prognosis of ovarian cancerUNIV WASHINGTON·Filed 2008·Application pending·0 cites
- 3849US2003219436A1Compositions and methods to regulate an immune response using CD83 gene expressed in tumors and using soluble CD83-Ig fusion proteinFiled 2002·Application pending·0 cites
- 3949US2004058445A1Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BBFiled 2002·Application pending·0 cites
- 4043US2011300186A1Functionalized Nano- and Micro-materials for Medical TherapiesHELLSTROM KARL ERIK·Filed 2011·Application pending·0 cites
- 4142US2007286860A1Compositions and Methods for Inducing Anti-Tumor ImmunityWASHINGTON RES FOUND·Filed 2005·Application pending·0 cites
- 4241US5411884AMonoclonal antibody L53 which recognizes a human tumor-associated antigenONCOGEN·Filed 1993·Granted May 2, 1995·8 cites·13 claims
- 4340US2011104675A1Methods and Compositions for Diagnosing CarcinomasPACIFIC NORTHWEST RES INST·Filed 2010·Application pending·0 cites
- 4437US5766588ATumor immunotherapy using anti-idiotypic antibodiesONCOGEN·Filed 1995·Granted Jun 16, 1998·1 cites·21 claims
- 4536US4873188AMethod, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodiesONCOGEN·Filed 1985·Granted Oct 10, 1989·5 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Ingegerd Hellstrom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →